Gyre Therapeutics COO Ye Weiguo disposes of USD 87,450 common sharesPUBT·Jun 22 at 03:03 PMGYRE-1.16%
Gyre updates corporate presentation detailing pipeline, China strategy and regulatory progressTradingView·Jun 2 at 05:13 AMGYRE-1.16%
Gyre Therapeutics to present CG923308 data; expects IND submission Q1 2027TradingView·May 14 at 04:33 PMGYRE-1.16%
Gyre Therapeutics | 10-Q: FY2026 Q1 Revenue Misses Estimate at USD 22.52 MEarnings Watch·May 8 at 03:25 PMGYRE-1.16%
Gyre Therapeutics | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 22.52 MEarnings Watch·May 7 at 10:24 PMGYRE-1.16%
Ying Luo Sells 10,136 Shares of Gyre Therapeutics (NASDAQ:GYRE) StockMarket Beat·May 7 at 09:15 PMGYRE-1.16%
Gyre Therapeutics (NASDAQ:GYRE) Shares Down 11.4% on Disappointing EarningsMarket Beat·May 7 at 11:54 AMGYRE-1.16%
Gyre Therapeutics shares are trading lower after the company reported worse-than-expected Q1 sales results.benzinga_article·May 7 at 11:23 AMGYRE-1.16%
Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company | GYRE Stock NewsStockTitan·May 3 at 11:47 PMGYRE-1.16%
